ニュース
The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...
Cigna has announced a deal to cap client copays on popular GLP-1 weight loss drugs by Eli Lilly and Novo Nordisk at $200 per ...
Evernorth has capped antiobesity drug monthly co-pays at $200 in a move to improve access and affordability amid new drug ...
Photo: Scott Olson () Getting access to popular weight loss drugs will be simpler and cheaper for some. Health insurer Cigna ...
For a limited time, Wegovy will be available to new patients at $199 for the first month, Novo Nordisk said Thursday.
Novo Nordisk said on Thursday it would offer temporary discounts to cash-paying customers for its weight-loss drug Wegovy, in ...
An investigation by The Guardian finds the insurance giant UnitedHealth Group quietly paid thousands in bonuses to nursing home facilities that helped it gain Medicare enrollees and reduce ...
U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...
Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...
Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...
Experts say it’s no surprise that UnitedHealthcare often ends up in the crosshairs of public and political scrutiny, as it’s ...
Cigna’s Evernorth unit scored a deal with Eli Lilly and Novo Nordisk to make weight loss drugs more affordable for insured ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する